The SOX4-Semaphorin3C axis promotes esophageal adenocarcinoma progression. [PDF]
Fnu T +13 more
europepmc +1 more source
An Atypical Case of Metastatic Esophageal Adenocarcinoma Causing Biliary Obstruction and Duodenal Infiltration Requiring EUS-Guided Choledochoduodenostomy. [PDF]
Attieh P +3 more
europepmc +1 more source
Causal relationship between GM, immune cells and esophageal adenocarcinoma: a mediation analysis based on MR. [PDF]
He W +12 more
europepmc +1 more source
CT-Guided Percutaneous Cryoablation of a Renal Metastasis From Esophageal Adenocarcinoma. [PDF]
Mina D +4 more
europepmc +1 more source
Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis. [PDF]
Beernaert B +31 more
europepmc +1 more source
The role of diagnostic laparoscopy in staging distal esophageal adenocarcinoma. [PDF]
Tsui ST +14 more
europepmc +1 more source
Chemotherapy for Esophageal Adenocarcinoma
Esophageal and esophagogastric junction adenocarcinoma is a distinct entity from esophageal squamous cell carcinoma with respect to etiology and biology despite sharing the same anatomical location. While most international treatment guidelines recommend a similar management strategy for both esophageal squamous and adenocarcinoma histologies, the ...
Ka-On, Lam, Dora L W, Kwong
openaire +3 more sources
Related searches:
Epidemiology of esophageal adenocarcinoma
Journal of Surgical Oncology, 2005AbstractThe incidence of esophageal adenocarcinoma has risen rapidly over the past 25 years in the United States as well as in several Western European countries. This increase had been most dramatic among white males. The majority of these cancers arise from a background of premalignant Barrett esophagus.
Luis Grande +2 more
exaly +3 more sources
Radiotherapy for Esophageal Adenocarcinoma
Adenocarcinomas occur in distal esophagus and often involve esophagogastric junction. Radiotherapy plays a key role in treatment, often in combination with chemotherapy and surgery in multi-modalities management. For resectable esophageal primaries, neoadjuvant chemoradiotherapy plus surgery can downstage disease and improve outcome over surgery alone.
Dora L W, Kwong, K O, Lam
openaire +3 more sources
Target Therapy for Esophageal Adenocarcinoma
Adenocarcinoma of the esophagus is a deadly disease and median survival of patients with metastatic disease is around 1 year only. There is an unmet need to personalize treatment by identifying molecular targets and respective target therapy in esophageal adenocarcinoma.
Ka-On, Lam, Dora L W, Kwong
openaire +3 more sources

